Skip to main content

Advertisement

SpringerLink
Log in

Gastrointestinal stromal tumors

  • Review Article
  • Published:
Pediatric Surgery International Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

References

  1. Fletcher CD, Berman JJ, Corless C, Gorstein F, Lasota J, Longley BJ, Miettinen M, O’Leary TJ, Remotti H, Rubin BP, Shmookler B, Sobin LH, Weiss SW (2002) Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol 33(5):459–465

    Article  PubMed  Google Scholar 

  2. Miettinen M, El-Rifai W, Sobin HL, Lasota J (2002) Evaluation of malignancy and prognosis of gastrointestinal stromal tumors: a review. Hum Pathol 33(5):478–483

    Article  PubMed  CAS  Google Scholar 

  3. Mazur MT, Clark HB (1983) Gastric stromal tumors. Reappraisal of histogenesis. Am J Surg Pathol 7(6):507–519

    PubMed  CAS  Google Scholar 

  4. Lauwers GY, Erlandson RA, Casper ES et al (1993) Gastrointestinal autonomic nerve tumors. A clinicopathological, immunohistochemical, and ultrastructural study of 12 cases. Am J Surg Pathol 17(9):887–897

    Article  PubMed  CAS  Google Scholar 

  5. Allander SV, Nupponen NN, Ringnér M, Hostetter G, Maher GW, Goldberger N, Chen Y, Carpten J, Elkahloun AG, Meltzer PS (2001) Gastrointestinal stromal tumors with KIT mutations exhibit a remarkably homogeneous gene expression profile. Cancer Res 61(24):8624–8628

    PubMed  CAS  Google Scholar 

  6. Miettinen M, Majidi M, Lasota J (2002) Pathology and diagnostic criteria of gastrointestinal stromal tumors (GISTs): a review. Eur J Cancer 38(Suppl 5):S39–S51

    Article  PubMed  Google Scholar 

  7. Hirota S, Isozaki K, Moriyama Y et al (1998) Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 279(5350):577–580

    Article  PubMed  CAS  Google Scholar 

  8. Dow N, Giblen G, Sobin LH, Miettinen M (2006) Gastrointestinal stromal tumors: differential diagnosis. Semin Diagn Pathol 23(2):111–119

    Article  PubMed  Google Scholar 

  9. Liegl B, Hornick JL, Corless CL, Fletcher CD (2009) Monoclonal antibody DOG1.1 shows higher sensitivity than KIT in the diagnosis of gastrointestinal stromal tumors, including unusual subtypes. Am J Surg Pathol 33(3):437–446

    Article  PubMed  Google Scholar 

  10. Medeiros F, Corless CL, Duensing A, Hornick JL, Oliveira AM, Heinrich MC, Fletcher JA, Fletcher CD (2004) KIT-negative gastrointestinal stromal tumors: proof of concept and therapeutic implications. Am J Surg Pathol 28(7):889–894

    Article  PubMed  Google Scholar 

  11. Hornick JL, Fletcher CD (2002) Immunohistochemical staining for KIT (CD117) in soft tissue sarcomas is very limited in distribution. Am J Clin Pathol 117(2):188–193

    Article  PubMed  Google Scholar 

  12. Miettinen M, Kopczynski J, Makhlouf HR, Sarlomo-Rikala M, Gyorffy H, Burke A, Sobin LH, Lasota J (2003) Gastrointestinal stromal tumors, intramural leiomyomas, and leiomyosarcomas in the duodenum: a clinicopathologic, immunohistochemical, and molecular genetic study of 167 cases. Am J Surg Pathol 27(5):625–641

    Article  PubMed  Google Scholar 

  13. Hasegawa T, Matsuno Y, Shimoda T, Hirohashi S (2002) Gastrointestinal stromal tumor: consistent CD117 immunostaining for diagnosis, and prognostic classification based on tumor size and MIB-1 grade. Hum Pathol 33(6):669–676

    Article  PubMed  Google Scholar 

  14. Vallböhmer D, Marcus HE, Baldus SE, Brabender J, Lurje G, Drebber U, Metzger R, Hölscher AH, Schneider PM (2008) Comparative analysis of four histopathological classification systems to discriminate benign and malignant behaviour in gastrointestinal stromal tumors. Anticancer Res 28(1B):367–372

    PubMed  Google Scholar 

  15. Franquemont DW (1995) Differentiation and risk assessment of gastrointestinal stromal tumors. Am J Clin Pathol 103(1):41–47

    PubMed  CAS  Google Scholar 

  16. Miettinen M, Blay JY, Sobin LH (2000) Mesenchymal tumours of the stomach. In: Hamilton SR, Aaltonen LA (eds) World Health Organization classification of tumours. Pathology and genetics of the digestive system, 1st edn. IARC Press, Lyon, pp 62–65

    Google Scholar 

  17. Dematteo RP, Heinrich MC, El-Rifai WM, Demetri G (2002) Clinical management of gastrointestinal stromal tumors: before and after STI-571. Hum Pathol 33(5):466–477

    Article  PubMed  CAS  Google Scholar 

  18. Miettinen M, Sobin LH, Lasota J (2009) Gastrointestinal stromal tumors presenting as omental masses—a clinicopathologic analysis of 95 cases. Am J Surg Pathol May 13

  19. Singer S, Rubin BP, Lux ML, Chen CJ, Demetri GD, Fletcher CD, Fletcher JA (2002) Prognostic value of KIT mutation type, mitotic activity, and histologic subtype in gastrointestinal stromal tumors. J Clin Oncol 20(18):3898–3905

    Article  PubMed  CAS  Google Scholar 

  20. Edmondson J, Marks R, Buckner J et al (1999) Contrast of response to d-MAP + sargramostim between patients with advance malignant gastrointestinal stromal tumours and patients with other advanced leiomyosarcomas. Proc ASCO 18:54a,

    Google Scholar 

  21. Plaat BE, Hollema H, Molenaar WM, Torn Broers GH, Pijpe J, Mastik MF, Hoekstra HJ, van den Berg E, Scheper RJ, van der Graaf WT (2000) Soft tissue leiomyosarcomas and malignant gastrointestinal stromal tumors: differences in clinical outcome and expression of multidrug resistance proteins. J Clin Oncol 18(18):3211–3220

    PubMed  CAS  Google Scholar 

  22. DeMatteo RP, Lewis JJ, Leung D, Mudan SS, Woodruff JM, Brennan MF (2000) Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg 231(1):51–58

    Article  PubMed  CAS  Google Scholar 

  23. Mudan SS, Conlon KC, Woodruff JM, Lewis JJ, Brennan MF (2000) Salvage surgery for patients with recurrent gastrointestinal sarcoma: prognostic factors to guide patient selection. Cancer 88(1):66–74

    Article  PubMed  CAS  Google Scholar 

  24. Agaram NP, Laquaglia MP, Ustun B, Guo T, Wong GC, Socci ND, Maki RG, DeMatteo RP, Besmer P, Antonescu CR (2008) Molecular characterization of pediatric gastrointestinal stromal tumors. Clin Cancer Res 14(10):3204–3215

    Article  PubMed  CAS  Google Scholar 

  25. Agaimy A, Wünsch PH, Sobin LH, Lasota J, Miettinen M (2006) Occurrence of other malignancies in patients with gastrointestinal stromal tumors. Semin Diagn Pathol 23(2):120–129

    Article  PubMed  Google Scholar 

  26. Miettinen M, Kraszewska E, Sobin LH, Lasota J (2008) A nonrandom association between gastrointestinal stromal tumors and myeloid leukemia. Cancer 112(3):645–649

    Article  PubMed  Google Scholar 

  27. Carballo M, Roig I, Aguilar F, Pol MA, Gamundi MJ, Hernan I, Martinez-Gimeno M (2005) Novel c-KIT germline mutation in a family with gastrointestinal stromal tumors and cutaneous hyperpigmentation. Am J Med Genet A 132(4):361–364

    PubMed  Google Scholar 

  28. Corless CL, Fletcher JA, Heinrich MC (2004) Biology of gastrointestinal stromal tumors. J Clin Oncol 22(18):3813–3825

    Article  PubMed  CAS  Google Scholar 

  29. Rasmussen SA, Friedman JM (2000) NF1 gene and neurofibromatosis 1. Am J Epidemiol 151(1):33–40

    PubMed  CAS  Google Scholar 

  30. Miettinen M, Fetsch JF, Sobin LH, Lasota J (2006) Gastrointestinal stromal tumors in patients with neurofibromatosis 1: a clinicopathologic and molecular genetic study of 45 cases. Am J Surg Pathol 30(1):90–96

    Article  PubMed  Google Scholar 

  31. Pasini B, McWhinney SR, Bei T, Matyakhina L, Stergiopoulos S, Muchow M, Boikos SA, Ferrando B, Pacak K, Assie G, Baudin E, Chompret A, Ellison JW, Briere JJ, Rustin P, Gimenez-Roqueplo AP, Eng C, Carney JA, Stratakis CA (2008) Clinical and molecular genetics of patients with the Carney–Stratakis syndrome and germline mutations of the genes coding for the succinate dehydrogenase subunits SDHB, SDHC, and SDHD. Eur J Hum Genet 16(1):79–88

    Article  PubMed  CAS  Google Scholar 

  32. Schiavi F, Boedeker CC, Bausch B et al (2005) Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC gene. JAMA 294(16):2057–2063

    Article  PubMed  CAS  Google Scholar 

  33. Matyakhina L, Bei TA, McWhinney SR, Pasini B, Cameron S, Gunawan B, Stergiopoulos SG, Boikos S, Muchow M, Dutra A, Pak E, Campo E, Cid MC, Gomez F, Gaillard RC, Assie G, Füzesi L, Baysal BE, Eng C, Carney JA, Stratakis CA (2007) Genetics of Carney triad: recurrent losses at chromosome 1 but lack of germline mutations in genes associated with paragangliomas and gastrointestinal stromal tumors. J Clin Endocrinol Metab 92(8):2938–2943

    Article  PubMed  CAS  Google Scholar 

  34. Schmahl J, Raymond CS, Soriano P (2007) PDGF signaling specificity is mediated through multiple immediate early genes. Nat Genet 39:52–60

    Article  PubMed  CAS  Google Scholar 

  35. Selak MA, Armour SM, MacKenzie ED, Boulahbel H, Watson DG, Mansfield KD, Pan Y, Simon MC, Thompson CB, Gottlieb E (2005) Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. Cancer Cell 7(1):77–85

    Article  PubMed  CAS  Google Scholar 

  36. Corless CL, McGreevey L, Haley A, Town A, Heinrich MC (2002) KIT mutations are common in incidental gastrointestinal stromal tumors one centimeter or less in size. Am J Pathol 160(5):1567–1572

    PubMed  CAS  Google Scholar 

  37. O’Sullivan MJ, McCabe A, Gillett P, Penman ID, MacKinlay GA, Pritchard J (2005) Multiple gastric stromal tumors in a child without syndromic association lacks common KIT or PDGFR alpha mutations. Pediatr Dev Pathol 8(6):685–689

    Article  PubMed  Google Scholar 

  38. Prakash S, Sarran L, Socci N, DeMatteo RP, Eisenstat J, Greco AM, Maki RG, Wexler LH, LaQuaglia MP, Besmer P, Antonescu CR (2005) Gastrointestinal stromal tumors in children and young adults: a clinicopathologic, molecular, and genomic study of 15 cases and review of the literature. J Pediatr Hematol Oncol 27(4):179–187

    Article  PubMed  Google Scholar 

  39. Janeway KA, Liegl B, Harlow A, Le C, Perez-Atayde A, Kozakewich H, Corless CL, Heinrich MC, Fletcher JA (2007) Pediatric KIT wild-type and platelet-derived growth factor receptor alpha-wild-type gastrointestinal stromal tumors share KIT activation but not mechanisms of genetic progression with adult gastrointestinal stromal tumors. Cancer Res 67(19):9084–9088

    Article  PubMed  CAS  Google Scholar 

  40. Antonescu CR, Viale A, Sarran L, Tschernyavsky SJ, Gonen M, Segal NH, Maki RG, Socci ND, DeMatteo RP, Besmer P (2004) Gene expression in gastrointestinal stromal tumors is distinguished by KIT genotype and anatomic site. Clin Cancer Res 10(10):3282–3290

    Article  PubMed  CAS  Google Scholar 

  41. Agaimy A, Pelz AF, Corless CL, Wünsch PH, Heinrich MC, Hofstaedter F, Dietmaier W, Blanke CD, Wieacker P, Roessner A, Hartmann A, Schneider-Stock R (2007) Epithelioid gastric stromal tumours of the antrum in young females with the Carney triad: a report of three new cases with mutational analysis and comparative genomic hybridization. Oncol Rep 18(1):9–15

    PubMed  CAS  Google Scholar 

  42. Heinrich MC, Rubin BP, Longley BJ, Fletcher JA (2002) Biology and genetic aspects of gastrointestinal stromal tumors: KIT activation and cytogenetic alterations. Hum Pathol 33(5):484–495

    Article  PubMed  CAS  Google Scholar 

  43. Besmer P (1991) The kit ligand encoded at the murine Steel locus: a pleiotropic growth and differentiation factor. Curr Opin Cell Biol 3(6):939–946

    Article  PubMed  CAS  Google Scholar 

  44. Besmer P (1997) Kit-ligand-stem cell factor. Colony-stimulating factors. Molecular and cell biology, 2nd edn. Marcel Dekker, New York, pp 369–404

  45. Heinrich MC, Owzar K, Corless CL, Hollis D, Borden EC, Fletcher CD, Ryan CW, von Mehren M, Blanke CD, Rankin C, Benjamin RS, Bramwell VH, Demetri GD, Bertagnolli MM, Fletcher JA (2008) Correlation of kinase genotype and clinical outcome in the North American Intergroup Phase III Trial of imatinib mesylate for treatment of advanced gastrointestinal stromal tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncology Group. J Clin Oncol 26(33):5360–5367

    Article  PubMed  CAS  Google Scholar 

  46. Blanke CD, von Mehren M, Joensuu H et al (2001) Evaluation of the molecularly targeted therapy STI 571 in patients with unresectable or metastatic gastrointestinal stromal tumors expressing KIT. ASCO Proc 20:2

    Google Scholar 

  47. Van den Abbeele, GIST collaborative Pet Study Group (2001) F18-FDG-PET provides early evidence of biological response to STI 571 in patients with malignant gastrointestinal stroma tumors (GIST). ASCO Proc 20:144

    Google Scholar 

  48. Liegl B, Hornick JL, Antonescu CR, Corless CL, Fletcher CD (2009) Rhabdomyosarcomatous differentiation in gastrointestinal stromal tumors after tyrosine kinase inhibitor therapy: a novel form of tumor progression. Am J Surg Pathol 33(2):218–226

    Article  PubMed  Google Scholar 

  49. Heinrich MC, Corless CL, Blanke CD, Demetri GD, Joensuu H, Roberts PJ, Eisenberg BL, von Mehren M, Fletcher CD, Sandau K, McDougall K, Ou WB, Chen CJ, Fletcher JA (2006) Molecular correlates of imatinib resistance in gastrointestinal stromal tumors. J Clin Oncol 24(29):4764–4774

    Article  PubMed  CAS  Google Scholar 

  50. Antonescu CR, Besmer P, Guo T, Arkun K, Hom G, Koryotowski B, Leversha MA, Jeffrey PD, Desantis D, Singer S, Brennan MF, Maki RG, DeMatteo RP (2005) Acquired resistance to imatinib in gastrointestinal stromal tumor occurs through secondary gene mutation. Clin Cancer Res 11(11):4182–4190

    Article  PubMed  CAS  Google Scholar 

  51. Bauer S, Yu LK, Demetri GD, Fletcher JA (2006) Heat shock protein 90 inhibition in imatinib-resistant gastrointestinal stromal tumor. Cancer Res 66(18):9153–9161

    Article  PubMed  CAS  Google Scholar 

  52. Sambol EB, Ambrosini G, Geha RC, Kennealey PT, Decarolis P, O’connor R, Wu YV, Motwani M, Chen JH, Schwartz GK, Singer S (2006) Flavopiridol targets c-KIT transcription and induces apoptosis in gastrointestinal stromal tumor cells. Cancer Res 66(11):5858–5866

    Article  PubMed  CAS  Google Scholar 

  53. Raut CP, Ashley SW (2008) How I do it: surgical management of gastrointestinal stromal tumors. J Gastrointest Surg 12:1592–1599

    Article  PubMed  Google Scholar 

  54. Demetri GD, Benjamin RS, Blanke CD et al (2007) NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST)—update of the NCCN clinical practice guidelines. J Natl Compr Cancer Netw 5(Suppl 2):S1–29 (quiz S30)

    Google Scholar 

  55. Agaimy A, Wünsch PH, Hofstaedter F, Blaszyk H, Rümmele P, Gaumann A, Dietmaier W, Hartmann A (2007) Minute gastric sclerosing stromal tumors (GIST tumorlets) are common in adults and frequently show c-KIT mutations. Am J Surg Pathol 31(1):113–120

    Article  PubMed  Google Scholar 

  56. Kawanowa K, Sakuma Y, Sakurai S, Hishima T, Iwasaki Y, Saito K, Hosoya Y, Nakajima T, Funata N (2006) High incidence of microscopic gastrointestinal stromal tumors in the stomach. Hum Pathol 37(12):1527–1535

    Article  PubMed  Google Scholar 

  57. Raut CP, Posner M, Desai J, Morgan JA, George S, Zahrieh D, Fletcher CD, Demetri GD, Bertagnolli MM (2006) Surgical management of advanced gastrointestinal stromal tumors after treatment with targeted systemic therapy using kinase inhibitors. J Clin Oncol 24(15):2325–2331

    Article  PubMed  CAS  Google Scholar 

  58. Janeway KA, Albritton KH, Van Den Abbeele AD, D’Amato GZ, Pedrazzoli P, Siena S, Picus J, Butrynski JE, Schlemmer M, Heinrich MC, Demetri GD (2009) Sunitinib treatment in pediatric patients with advanced GIST following failure of imatinib. Pediatr Blood Cancer 52(7):767–771

    Article  PubMed  Google Scholar 

  59. Scotlandi K, Picci P (2008) Targeting insulin-like growth factor 1 receptor in sarcomas. Curr Opin Oncol 20(4):419–427

    Article  PubMed  CAS  Google Scholar 

  60. Tarn C, Rink L, Merkel E, Flieder D, Pathak H, Koumbi D, Testa JR, Eisenberg B, von Mehren M, Godwin AK (2008) Insulin-like growth factor 1 receptor is a potential therapeutic target for gastrointestinal stromal tumors. Proc Natl Acad Sci USA 105(24):8387–8392

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

I wish to acknowledge the generous permission of Professor Jonathan A. Fletcher for the use of the schematic in Fig. 2 and also for helpful comments regarding the contents of this manuscript. I acknowledge Dr. Cian Muldoon for providing the sections of rectal leiomyoma depicted in Fig. 1d–f and David Grehan and John O’Brien for their excellent technical support in providing immunohistochemical staining of the samples depicted in Fig. 1. Dr. Jenny Watson kindly proof-read the manuscript.

Author information

Authors and Affiliations

  1. Consultant Paediatric Pathologist, Our Lady’s Children’s Hospital, Crumlin, Dublin 12, Ireland

    Maureen J. O’Sullivan

Authors
  1. Maureen J. O’Sullivan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Maureen J. O’Sullivan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

O’Sullivan, M.J. Gastrointestinal stromal tumors. Pediatr Surg Int 25, 841–850 (2009). https://doi.org/10.1007/s00383-009-2477-9

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00383-009-2477-9

Keywords

Search

Navigation